Andy Holt

Chief Commercial Officer • Cellistic

Andy Holt brings more than fifteen years of experience in cell and gene therapy to Cellistic. In his prior roles, he held business development, corporate development and management positions for CDMOs, driving commercial strategy and growth in adeno-associated virus (AAV) gene therapy manufacturing. In his role at Cellistic, Andy leverages his experience in scaling up cell and gene therapy platforms to help Cellistic clients reach their goals in allogeneic cell therapy.

Also Speaking

David Chang

Chief Executive Officer • WuXi Advanced Therapies

Amritha Jaishankar

Executive Director, Cell and Gene Therapy Center • IQVIA

Gwen Nichols

Chief Medical Officer • The Leukemia & Lymphoma Society

Also Speaking


Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.


Find out more and apply to get involved at the briefings taking place at Advanced Therapies Week.